Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Sanofi consumer up, but Viehbacher out; GNC looks for better mix; Pfizer consumer enjoys Nexium boost; USANA pivots to new incentives; Implus reaches TriggerPoint; and supplement GMP, unapproved drug warnings